{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:06:19Z","timestamp":1792785979990,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015831","name":"Radius","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015831","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bone loss below the level of neurological lesion is a well-known complication of spinal cord injury (SCI). To date, most research has focused on pharmaceutical intervention using antiresorptives to prevent bone loss during the acute phase of SCI; however, limited research has investigated treatments for established osteoporosis during chronic SCI. Romosozumab, a monoclonal antibody with both antiresorptive and anabolic effects, has demonstrated significant increases in BMD for women with established PMO. Therefore, the purpose of this study was to examine the efficacy of monthly treatment with romosozumab to improve DXA-derived areal BMD at the hip, and CT-derived BMC and strength at the hip and knee in women with chronic SCI and an inability to ambulate. Twelve female participants with chronic SCI were recruited to receive 1\u00a0yr of monthly subcutaneous injections of romosozumab (210\u00a0mg). DXA and CT scans were taken at baseline, and months 3, 6, and 12 to quantify bone mineral, and finite element (FE) analysis was used to predict bone strength. Longitudinal mixed effects models were employed to determine the impact of treatment on bone properties. After 12\u00a0mo of treatment, areal BMD at the lumbar spine and total hip were significantly increased with median changes of 10.2% (IQR: 8.3\u201315.2%, p&amp;lt;.001) and 4.2% (IQR: 3.4\u20137.7%, p\u00a0=\u00a0.009), respectively. Improvements at the hip were primarily due to increases in trabecular, not cortical, bone and effects were sufficient to significantly increase FE-predicted strength by 20.3% (IQR: 9.5\u201337.0%, p\u00a0=\u00a0.004). Treatment with romosozumab did not lead to any significant improvement in bone mineral at the distal femur or proximal tibia. These findings provide promising results for romosozumab treatment to improve bone mineral and reduce fracture risk at the hip, but not the knee, in women with chronic SCI.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziae077","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T02:28:42Z","timestamp":1717554522000},"source":"Crossref","is-referenced-by-count":10,"title":["Monthly treatment with romosozumab for 1 year increases bone mineral at the hip, but not the knee, in women with chronic spinal cord injury"],"prefix":"10.1093","volume":"8","author":[{"given":"Laura E","family":"Crack","sequence":"first","affiliation":[{"name":"Human Performance Lab , Faculty of Kinesiology, , Calgary, AB T2N 1N4 , Canada"},{"name":"University of Calgary , Faculty of Kinesiology, , Calgary, AB T2N 1N4 , Canada"},{"name":"McCaig Institute for Bone and Joint Health , Cumming School of Medicine, , Calgary, AB T2N 1N4 , Canada"},{"name":"University of Calgary , Cumming School of Medicine, , Calgary, AB T2N 1N4 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narina","family":"Simonian","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Schnitzer","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3623-9764","authenticated-orcid":false,"given":"W Brent","family":"Edwards","sequence":"additional","affiliation":[{"name":"Human Performance Lab , Faculty of Kinesiology, , Calgary, AB T2N 1N4 , Canada"},{"name":"University of Calgary , Faculty of Kinesiology, , Calgary, AB T2N 1N4 , Canada"},{"name":"McCaig Institute for Bone and Joint Health , Cumming School of Medicine, , Calgary, AB T2N 1N4 , Canada"},{"name":"University of Calgary , Cumming School of Medicine, , Calgary, AB T2N 1N4 , Canada"},{"name":"Department of Biomedical Engineering , Schulich School of Engineering, , Calgary, AB T2N 1N4 , Canada"},{"name":"University of Calgary , Schulich School of Engineering, , Calgary, AB T2N 1N4 , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,7]]},"reference":[{"issue":"2","key":"2024062311011406600_ref1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00198-005-2028-8","article-title":"Osteoporosis after spinal cord injury","volume":"17","author":"Jiang","year":"2006","journal-title":"Osteoporos Int"},{"issue":"6","key":"2024062311011406600_ref2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jbspin.2011.04.007","article-title":"Pathophysiology of bone loss in disuse osteoporosis","volume":"78","author":"Alexandre","year":"2011","journal-title":"Jt Bone Spine [Internet]"},{"issue":"3","key":"2024062311011406600_ref3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2362.1990.tb01865.x","article-title":"Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury","volume":"20","author":"Biering-S\u00f8rensen","year":"1990","journal-title":"Eur J Clin Invest"},{"key":"2024062311011406600_ref4","first-page":"937","article-title":"A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality","volume":"10","author":"Nazrun","year":"2014","journal-title":"Ther Clin Risk Manag"},{"issue":"3","key":"2024062311011406600_ref5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-008-0671-6","article-title":"Osteoporotic fractures and hospitalization risk in chronic spinal cord injury","volume":"20","author":"Morse","year":"2009","journal-title":"Osteoporos Int"},{"issue":"2","key":"2024062311011406600_ref6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apmr.2007.08.144","article-title":"Incidence of fractures in a cohort of veterans with chronic multiple sclerosis or traumatic spinal cord injury","volume":"89","author":"Logan","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"issue":"9","key":"2024062311011406600_ref7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00198-011-1879-4","article-title":"High dose compressive loads attenuate bone mineral loss in humans with spinal cord injury","volume":"23","author":"Dudley-Javoroski","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"2024062311011406600_ref8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2008.03.004","article-title":"High-volume FES-cycling partially reverses bone loss in people with chronic spinal cord injury","volume":"43","author":"Frotzler","year":"2008","journal-title":"Bone"},{"issue":"4","key":"2024062311011406600_ref9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/mus.21391","article-title":"Muscle after spinal cord injury","volume":"40","author":"Biering-S\u00f8rensen","year":"2009","journal-title":"Muscle Nerve"},{"issue":"4","key":"2024062311011406600_ref10","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1210\/jc.2006-2013","article-title":"Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study","volume":"92","author":"Gilchrist","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024062311011406600_ref11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1682\/JRRD.2004.05.0062","article-title":"Effect of pamidronate administration on bone in patients with acute spinal cord injury","volume":"42","author":"Bauman","year":"2005","journal-title":"J Rehabil Res Dev"},{"issue":"3","key":"2024062311011406600_ref12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0003-9993(99)90133-8","article-title":"Intravenous pamidronate attenuates bone density loss after acute spinal cord injury","volume":"80","author":"Nance","year":"1999","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"2024062311011406600_ref13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.3525","article-title":"Effects of teriparatide and vibration on bone mass and bone strength in people with bone loss and spinal cord injury: a randomized, controlled trial","volume":"33","author":"Edwards","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"16","key":"2024062311011406600_ref14","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"15","key":"2024062311011406600_ref15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"2024062311011406600_ref16","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00198-022-06544-2","article-title":"Romosozumab efficacy and safety in European patients enrolled in the FRAME trial","volume":"33","author":"Langdahl","year":"2022","journal-title":"Osteoporos Int [Internet]"},{"issue":"1","key":"2024062311011406600_ref17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jbmr.2932","article-title":"Effects of romosozumab compared with teriparatide on bone density and mass at the spine and hip in postmenopausal women with low bone mass","volume":"32","author":"Genant","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024062311011406600_ref18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcph.239","article-title":"Multiple doses of sclerostin antibody romosozumab in healthy men and postmenopausal women with low bone mass: a randomized, double-blind, placebo-controlled study","volume":"54","author":"Padhi","year":"2014","journal-title":"J Clin Pharmacol"},{"issue":"12","key":"2024062311011406600_ref19","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00198-023-06889-2","article-title":"Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis","volume":"34","author":"Hong","year":"2023","journal-title":"Osteoporos Int [Internet]"},{"issue":"4","key":"2024062311011406600_ref20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.11005\/jbm.2022.29.4.279","article-title":"Erratum: effect of romosozumab on trabecular bone score compared to anti-resorptive agents in postmenopausal women with osteoporosis (Journal of Bone Metabolism (2021) 28:4 (317\u2013323) DOI: 10.11005\/jbm.2021.28.4.317)","volume":"29","author":"Jeong","year":"2022","journal-title":"J Bone Metab"},{"issue":"2021","key":"2024062311011406600_ref21","doi-asserted-by":"crossref","first-page":"116209","DOI":"10.1016\/j.bone.2021.116209","article-title":"Romosozumab reduces incidence of new vertebral fractures across severity grades among postmenopausal women with osteoporosis","volume":"154","author":"Geusens","year":"2022","journal-title":"Bone"},{"issue":"10","key":"2024062311011406600_ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbm4.10211","article-title":"The effect of 1 year of romosozumab on the incidence of clinical vertebral fractures in postmenopausal women with osteoporosis: results from the FRAME study","volume":"3","author":"Geusens","year":"2019","journal-title":"JBMR Plus"},{"issue":"9","key":"2024062311011406600_ref23","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/jbmr.3176","article-title":"Greater gains in spine and hip strength for romosozumab compared with teriparatide in postmenopausal women with low bone mass","volume":"32","author":"Keaveny","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2024062311011406600_ref24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/\u03b2-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024062311011406600_ref25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00223-012-9610-9","article-title":"Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody","volume":"91","author":"Shahnazari","year":"2012","journal-title":"Calcif Tissue Int"},{"issue":"27","key":"2024062311011406600_ref26","doi-asserted-by":"crossref","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","article-title":"The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro","volume":"290","author":"Spatz","year":"2015","journal-title":"J Biol Chem [Internet]"},{"issue":"5","key":"2024062311011406600_ref27","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.2010-0067","article-title":"Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss","volume":"95","author":"Gaudio","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2024062311011406600_ref28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bone.2016.02.005","article-title":"Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse","volume":"87","author":"Zhang","year":"2016","journal-title":"Bone [Internet]"},{"issue":"1","key":"2024062311011406600_ref29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nyas.13991","article-title":"Retention of osteocytic micromorphology by sclerostin antibody in a concurrent ovariectomy and functional disuse model","volume":"1442","author":"Zhang","year":"2019","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"2024062311011406600_ref30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sc.2014.122","article-title":"Dual energy X-ray absorptiometry of the knee in spinal cord injury: methodology and correlation with quantitative computed tomography","volume":"52","author":"McPherson","year":"2014","journal-title":"Spinal Cord"},{"issue":"10","key":"2024062311011406600_ref31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.pmrj.2012.05.011","article-title":"Calcaneal quantitative ultrasound compared with hip and femoral neck dual-energy x-ray absorptiometry in people with a spinal cord injury","volume":"4","author":"Schnitzer","year":"2012","journal-title":"PM R"},{"issue":"8","key":"2024062311011406600_ref32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.pmrj.2013.03.032","article-title":"Effect of parathyroid hormone combined with gait training on bone density and bone architecture in people with chronic spinal cord injury","volume":"5","author":"Gordon","year":"2013","journal-title":"PM R"},{"issue":"9","key":"2024062311011406600_ref33","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00198-013-2323-8","article-title":"Bone mineral loss at the proximal femur in acute spinal cord injury","volume":"24","author":"Edwards","year":"2013","journal-title":"Osteoporos Int"},{"issue":"3","key":"2024062311011406600_ref34","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00198-013-2557-5","article-title":"Bone mineral and stiffness loss at the distal femur and proximal tibia in acute spinal cord injury","volume":"25","author":"Edwards","year":"2014","journal-title":"Osteoporos Int"},{"issue":"9","key":"2024062311011406600_ref35","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/jbmr.2227","article-title":"Reduction in proximal femoral strength in patients with acute spinal cord injury","volume":"29","author":"Edwards","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2024062311011406600_ref36","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.jbiomech.2013.04.016","article-title":"Torsional stiffness and strength of the proximal tibia are better predicted by finite element models than DXA or QCT","volume":"46","author":"Edwards","year":"2013","journal-title":"J Biomech [Internet]"},{"issue":"2","key":"2024062311011406600_ref37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10439-020-02606-w","article-title":"Stiffness and strength predictions from finite element models of the knee are associated with lower-limb fractures after spinal cord injury","volume":"49","author":"Haider","year":"2021","journal-title":"Ann Biomed Eng"},{"issue":"9","key":"2024062311011406600_ref38","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00198-023-06811-w","article-title":"Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability","volume":"34","author":"Crack","year":"2023","journal-title":"Osteoporos Int"},{"issue":"10","key":"2024062311011406600_ref39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41393-019-0303-3","article-title":"Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density","volume":"57","author":"Haider","year":"2019","journal-title":"Spinal Cord [Internet]"},{"issue":"3","key":"2024062311011406600_ref40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bone.2009.10.020","article-title":"Comparison of hip fracture risk prediction by femoral aBMD to experimentally measured factor of risk","volume":"46","author":"Roberts","year":"2010","journal-title":"Bone [Internet]"},{"issue":"12","key":"2024062311011406600_ref41","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1359\/jbmr.080805","article-title":"Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans","volume":"23","author":"Keaveny","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024062311011406600_ref42","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/09638289209167081","article-title":"Minimal trauma causing fractures in patients with spinal cord injury","volume":"14","author":"Keating","year":"1992","journal-title":"Disabil Rehabil"},{"issue":"7","key":"2024062311011406600_ref43","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0020-1383(02)00163-8","article-title":"Late lower extremity fractures in patients with paraplegia","volume":"33","author":"Martinez","year":"2002","journal-title":"Int J Care Inj"},{"issue":"8","key":"2024062311011406600_ref44","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/jbmr.2474","article-title":"Reduction in torsional stiffness and strength at the proximal tibia as a function of time since spinal cord injury","volume":"30","author":"Edwards","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024062311011406600_ref45","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00198-020-05705-5","article-title":"Exploring changes in bone mass in individuals with a chronic spinal cord injury","volume":"32","author":"El-Kotob","year":"2021","journal-title":"Osteoporos Int"},{"issue":"2","key":"2024062311011406600_ref46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/jbmr.546","article-title":"Association between sclerostin and bone density in chronic spinal cord injury","volume":"27","author":"Morse","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2024062311011406600_ref47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11914-012-0117-0","article-title":"Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies","volume":"10","author":"Battaglino","year":"2012","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"2024062311011406600_ref48","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00198-011-1654-6","article-title":"Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study","volume":"23","author":"M\u00f8ller","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"2024062311011406600_ref49","first-page":"1","article-title":"Pregnancy and lactation-associated osteoporosis successfully treated with romosozumab: a case report","volume":"59","author":"Kaneuchi","year":"2023","journal-title":"Medicina"},{"issue":"5","key":"2024062311011406600_ref50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10790268.2008.11753650","article-title":"Five-year longitudinal bone evaluations in individuals with chronic complete spinal cord injury","volume":"31","author":"Garland","year":"2008","journal-title":"J Spinal Cord Med"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziae077\/58166561\/ziae077.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/7\/ziae077\/58308360\/ziae077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/8\/7\/ziae077\/58308360\/ziae077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T07:01:51Z","timestamp":1719126111000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziae077\/7689629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,5,31]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziae077","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,5,31]]},"article-number":"ziae077"}}